Is Stevanato Group SpA overvalued or undervalued?

As of 30 June 2025, the valuation grade for Stevanato Group SpA moved from expensive to attractive, indicating a shift towards being undervalued. The company is currently assessed as attractive, with a P/E ratio of 47, a Price to Book Value of 4.24, and an EV to EBITDA of 26.56. In comparison, peers such as TransMedics Group, Inc. have a P/E of 50.23 and an EV to EBITDA of 37.01, while LeMaitre Vascular, Inc. shows a P/E of 49.77 and an EV to EBITDA of 33.90, suggesting that Stevanato Group may offer better value relative to its peers.
The stock has performed well against the S&P 500, with a year-to-date return of 25.06% compared to the S&P 500's 12.22%, and a one-year return of 38.04% versus 17.14% for the index, reinforcing the attractiveness of the stock. Overall, Stevanato Group SpA appears to be undervalued based on its current valuation metrics and strong recent performance.